Uplizna 75987-0150
Generic: Inebilizumab
Product NDC
75987-0150- Manufacturer
- Horizon Therapeutics Usa, Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 11, 2020
- Listing Expires
- December 31, 2026
- Application
- BLA761142
Need to source Uplizna? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Inebilizumab | 10 mg/mL |
Drug Class
CD19-directed Cytolytic Antibody [EPC]CD19-directed Antibody Interactions [MoA]CD19-directed Cytolytic Antibody [EPC]
Packaging Options(1)
3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03) / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01)